Showing results (201-210 of 239) with videos related to

Sort By:
Pageof 24
Kidney International Reports|July 18, 2025
Urinary Clusterin is a Biomarker of Renal Epithelial Senescence and Predicts Human Kidney Disease ProgressionDavid P Baird, Maximilian Reck, Ross Campbell, et al.
Nature Communications|October 15, 2025
Low circulating miR-190a-5p predicts progression of chronic kidney diseaseDavid P Baird, Jinnan Zang, Katie L Connor, et al.
European Journal of Heart Failure|May 24, 2024
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trialCarolyn S P Lam, Lars Køber, Koichiro Kuwahara, et al.
Diabetes Care|July 8, 2018
Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 DiabetesAndreas Heinzel, Michael Kammer, Gert Mayer, et al.
BMC Nephrology|March 4, 2025
Analysis of the kidney failure risk equation implementation in routine clinical practice and health inequalities in chronic kidney disease care: a retrospective cohort studyHeather Walker, Shabana Khan, Sandosh Padmanabhan, et al.
Kidney360|April 4, 2022
Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL TrialPatrick B Mark, Pardeep S Jhund, Matthew R Walters, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2020
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled TrialMiles D Witham, Jennifer S Lees, Myra White, et al.
ESC Heart Failure|May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and designJaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Diabetes Care|December 20, 2019
Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK BiobankClaire Welsh, Paul Welsh, Carlos A Celis-Morales, et al.
Kidney International|November 5, 2019
Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetesMichael Kammer, Andreas Heinzel, Jill A Willency, et al.
Pageof 24